top of page


Our Services:
  • Diagnosis of Adult and Pediatric Movement and Neurodegenerative Disorders

  • Injections of Botulinum Toxins (Botox, Xeomin, Myobloc)

  • Neurogenetics

  • Deep Brain Stimulation

  • Neuravive, MR-guided focused ultrasound treatment for refractory essential tremor

  • EMG

  • Clinical Research Trials

  • Huntington Disease Center of Excellence

  • Telemedicine (

Where To Find Us >
Latest Clinic News:
  • Several new clinical trials for patients with Parkinson's disease (Inhibikinase, Intracellular Therapies, Cerevance, and Scion NeuroStim) are open to enrollment

  • The Food and Drug Administration (FDA) has approved Daxxify® (daxibotulinumtoxinA- lanm) for the treatment of cervical dystonia in adults

  • Cerevel Study to Evaluate the Efficacy, Safety and Tolerability of Tavapadon in Early Parkinson's Disease (TEMPO-2 TRIAL) - enrollment completed

  • Cerevel Study to Evaluate the Efficacy, Safety and Tolerability of Tavapadon as Adjunctive Therapy for Parkinson's Disease in Levodopa-Treated Adults with Motor Fluctuations (TEMPO-3 TRIAL) - enrollment completed

  • Pharma2B Study of Parkinson Disease - P2B001 had superior efficacy to its individual components and was comparable with commercially used doses of pramipexole-ER with less worsening of sleepiness and fewer dopaminergic adverse events

  • LEGATO study of HD:  laquinimod significantly reduced caudate volume loss compared with placebo at week 52

  • Dr. LeDoux serves his second term on the Dystonia Medical Research Foundation Medical & Scientific Advisory Council

  • Among cases presenting with blepharospasm in the Dystonia Coalition cohort, 61% experienced spread of dystonia to other regions, most commonly the oromandibular region and neck. 


Botulinum toxins

Botox - Xeomin - Myobloc
bottom of page